IFP Advisors, Inc - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2022$5,0001,5620.0%0.00%
Q4 2021$01,5620.0%0.00%
Q3 2021$01,5620.0%0.00%
Q2 2021$01,562
+2197.1%
0.00%
Q1 2021$0680.0%0.00%
Q4 2020$068
-41.4%
0.00%
Q3 2020$0
-100.0%
116
-79.1%
0.00%
Q3 2017$2,000
+100.0%
5550.0%0.00%
Q2 2017$1,0000.0%5550.0%0.00%
Q1 2017$1,0000.0%5550.0%0.00%
Q4 2016$1,000
-50.0%
5550.0%0.00%
Q3 2016$2,000
-60.0%
555
-64.9%
0.00%
Q2 2016$5,0000.0%1,581
+1.9%
0.00%
Q4 2015$5,0001,5510.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders